Results 31 to 40 of about 116,083 (186)
NTRK Fusions in 1113 Solid Tumors in a Single Institution
Most NTRK fusions occur at very low frequencies in various common cancers. Recent recommendations on NTRK testing recommend immunohistochemistry (IHC) as the initial test for tumor types with a low frequency of NTRK fusions.
Heejin Bang +7 more
doaj +1 more source
Pharmacological Topics of Bone Metabolism: A Novel Bisphosphonate for the Treatment of Periodontitis
It has been reported that the pharmacological characteristics of bisphosphonates vary depending on the side chain attached to the carbon atom of the P-C-P bond.
Hisashi Shinoda +4 more
doaj +1 more source
On Trk for Retrograde Signaling [PDF]
Target-derived neurotrophins like nerve growth factor (NGF) mediate biological effects by binding to and activating Trk neurotrophin receptors at nerve terminals. The activated Trk receptors then stimulate local effects at nerve terminals, and retrograde effects at neuronal cell bodies that often reside at considerable distances from the terminals ...
Miller, Freda D, Kaplan, David R
openaire +2 more sources
Keeping ‘Trk’ of Antidepressant Actions [PDF]
Despite growing evidence that increased brain-derived neurotrophic factor (BDNF) and hippocampal adult neurogenesis are necessary for the behavioral actions of antidepressants in rodents, the cellular mechanisms involved in these effects are still unknown. Li et al.
Banasr, Mounira, Duman, Ronald S.
openaire +2 more sources
Background Ischemia within the optic nerve head (ONH) may contribute to retinal ganglion cell (RGC) loss in primary open angle glaucoma (POAG). Ischemia has been reported to increase neurotrophin and high affinity Trk receptor expression by CNS neurons ...
Clark Abbot F +2 more
doaj +1 more source
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China
Gene fusions can drive tumor development for multiple types of cancer. Currently, many drugs targeting gene fusions are being approved for clinical application.
Chunwei Xu +110 more
doaj +1 more source
Background: NTRK1, NTRK2, and NTRK3 are members of the neurotrophic receptor tyrosine kinases (NTRK) family, which encode TrkA, TrkB, and TrkC receptors, respectively.
Fazil Ahmad +3 more
doaj +1 more source
Involvement of TRK receptors in the nootropic effect of cycloprolylglycine
Background. The neuropeptide cycloprolylglycine (CPG) is an endogenous dipeptide analogue of the nootropic piracetam. It has been experimentally shown that CPG (designed and synthesized at the Federal State Budgetary Scientific Institution «Federal ...
O. N. Vorontsova +5 more
doaj +1 more source
Background Tropomyosin receptor kinase (TRK) fusion proteins resulting from neurotrophic tyrosine receptor kinase (NTRK) gene fusions are rare primary oncogenic drivers in a wide array of tumors.
James C. H. Yang +15 more
doaj +1 more source
Background and purpose: The mature form of brain-derived neurotrophic factor (BDNF) binds to BDNF/NT-3 growth factors receptor (Trk-B). This binding leads to activation of Ras–MAPK pathway which is integrated with cell growth and proliferation.
Saeed Khalili +8 more
doaj

